Stockreport

Bausch Health Trial Miss Puts Liver Program And Valuation In Focus [Yahoo! Finance]

Bausch Health Companies Inc.  (BHC) 
Last bausch health companies inc. earnings: 2/19 06:59 am Check Earnings Report
PDF Bausch Health Companies (NYSE:BHC) reported Phase 3 RED-C trial results for amorphous rifaximin SSD in liver cirrhosis patients. The global trials did not meet their [Read more]